NRC Brachytherapy Licensing Modifications Give Doctors More Flexibility
This article was originally published in The Gray Sheet
Executive Summary
A revised Nuclear Regulatory Commission guidance for intravascular radiation therapy goes beyond an earlier guidance by allowing "source stepping" and by permitting radiation oncologists to prescribe the two currently approved brachytherapy systems, Cordis' Checkmate and Novoste's BetaCath, without being physically present during the procedure.
You may also be interested in...
NRC Brachytherapy Regs Go Beyond FDA To Restrict Physician Off-Label Use
The Nuclear Regulatory Commission's involvement in the regulation of vascular brachytherapy devices will restrict off-label use by physicians to investigational device exemption research and procedures cleared by the agency for compassionate use.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.